Home Browse Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer...
ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
▬
✚
Research Article
Revised

Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study

[version 2; peer review: 1 approved, 2 approved with reservations]
Manjunath Shetty
https://orcid.org/0000-0002-3106-3683
1,2, Smita Shenoy
https://orcid.org/0000-0002-7578-1855
3, Arul Amuthan2, [...] Vasudha Devi3, Nitesh Kumar
https://orcid.org/0000-0002-4929-3954
4, Amruth Kiran2, Ganesh Shenoy2, Diya Rajasekhar Chinta5, Shama Prasada K
https://orcid.org/0000-0002-4158-3893
6, Akshatha Shetty7, Mohandas Rao K G8
Manjunath Shetty
https://orcid.org/0000-0002-3106-3683
1,2, Smita Shenoy
https://orcid.org/0000-0002-7578-1855
3, [...] Arul Amuthan2, Vasudha Devi3, Nitesh Kumar
https://orcid.org/0000-0002-4929-3954
4, Amruth Kiran2, Ganesh Shenoy2, Diya Rajasekhar Chinta5, Shama Prasada K
https://orcid.org/0000-0002-4158-3893
6, Akshatha Shetty7, Mohandas Rao K G8
PUBLISHED 22 Oct 2024
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Manipal Academy of Higher Education gateway.

Abstract

Background

Hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. Hence cost-effective drugs with fewer side effects as a standard supportive therapy might yield substantial advantages in efficacy and safety. Kadukkai maathirai (KM) is being used as a supplement in hepatocellular carcinoma. We evaluated whether KM has any preventive action on cancer progression in diethyl nitrosamine (DEN) - induced HCC in rats.

Methods

DEN was injected to produce HCC in rats, which was confirmed after 16 weeks. All the rats were orally administered KM for 4 weeks. Hepatoprotective potential (serum AST, ALT, ALP, Bilirubin) and anticancer efficacy (body weight, nodule count, tumor progression by histopathology, expression of GSTM1 by Liquid chromatography-mass spectrometry (LC-MS), and In-silico analysis of phytoconstituents against β catenin and LRP analysis were evaluated.

Results

KM prevented cancer progression against DEN-induced HCC by an increase in GSTM1, a phase II detoxifying enzyme. It significantly reversed altered nodule count, relative liver weight, body weight, and histopathological features of HCC. In silico analysis of phytoconstituents of KM showed that they modulate the intracellular transcription process by inhibiting the armadillo repeat region of β catenin.

Conclusions

Our results elucidate the potential of KM as a supplement in HCC by reducing nodule count, protecting the liver from further damage, GSTM1 expression, and inhibiting armadillo repeat region of β catenin.

Keywords

β catenin, Glutathione-S transferase mu 1, Siddha, herbal, Diethyl nitrosamine

Corresponding author: Smita Shenoy
Competing interests: No competing interests were disclosed.
Grant information: The author(s) declared that no grants were involved in supporting this work.
Copyright:  © 2024 Shetty M et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to cite: Shetty M, Shenoy S, Amuthan A et al. Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2024, 13:639 (https://doi.org/10.12688/f1000research.145961.2) First published: 17 Jun 2024, 13:639 (https://doi.org/10.12688/f1000research.145961.1) Latest published: 22 Oct 2024, 13:639 (https://doi.org/10.12688/f1000research.145961.2)

Revised Amendments from Version 1

1.Author affiliations:
KG Mohandas Rao affiliation has been changed to correct an error.
2.Discussion:
Corrections have been made to explain the findings with reason wherever possible and improve the grammar. The reason for all findings cannot be explicitly stated as this requires detailed mechanistic study which is the future scope and is accordingly mentioned in the conclusion. Study findings have been linked to earlier reports in literature. Discussion has been organized to improve the flow. One  reference is deleted and one added as follows-
Reference 63 is deleted.
64 renumber as 63.
65 renumber as 64.
And new reference will be numbered as 65.
3. Conclusion:
Heading is corrected as Conclusion (instead of Conclusions). Conclusion has been corrected to reflect the potential role of Kadukkai maathirai in therapy along with further scope of the study.

To read any peer review reports and author responses for this article, follow the "read" links in the Open Peer Review table.

Introduction

Hepatocellular carcinoma (HCC) is among the sixth most common and the second most lethal cancers. 1 It may occur as a sequel to chronic liver conditions such as alcohol and tobacco consumption, obesity, and infections like hepatitis B, hepatitis C, and aflatoxins. 2 , 3 These factors lead to liver inflammation and fibrosis, followed by the destruction of the normal liver architecture.

Chemotherapy, radiotherapy, radiofrequency ablation, hepatectomy, and transplantation are the management plans of HCC. 4 However, the survival rate is low, suggesting the need for improved therapy. 5 Chemotherapeutic agents used include sorafenib (MAP-kinase inhibitor), doxorubicin, 5-fluorouracil (5-FU), and cisplatin. 6 Being a multikinase inhibitor sorafenib, acts on vascular endothelial growth factor (VEGF) receptors, and prolongs survival so this drug is considered as a new reference standard for advanced HCC. However, it elicits adverse effects including skin toxicities, diarrhea, and hypertension, along with other general toxicities like anorexia, hair loss, weight loss, etc. 7

Compared to conventional modes of treatment, plant-based medicines have generally fewer side effects, are cost-effective, and well tolerated by patients. 8 Kadukkai maathirai (KM) is an Indian traditional medicine prescribed by Siddha practitioners to treat edema in severe anemia and ascites secondary to liver disease. KM consists of Terminalia chebula Retz. (Combretaceae), Piper nigrum L. (Piperaceae), Eclipta alba L. (Asteraceae), Citrus L. (Rutaceae) and ferrous sulfate. 9 Each of the constituents mentioned is known to have a hepatoprotective effect. 10 T. chebula consists of gallic acid and chebulic acid; gallic acid has anti-inflammatory and antioxidant properties, whereas chebulic acid has antioxidant with hepatoprotective properties. 11 P. nigrum inhibits lipid peroxidation and superoxide free radical generation due to its antioxidant effect exerted by phenols and flavonoids. 12 , 13 Coumestans, present in E. alba, stimulates the regeneration of hepatocytes and protect the liver. 14

Though Kadukkai maathirai is used for treating liver disorders by practitioners of Siddha medicine, yet its effect on hepatocellular carcinoma has not been explored. Diethylnitrosamine (DEN) is a known potential hepatocarcinogen that disrupts nuclear enzymes that help in the repair of DNA and replication. 14 In our previous study we demonstrated that the KM at the dose of 144 mg/kg treatment exhibited significant protection which was evident both by histology and biochemically against D-galactosamine-induced hepatic necrosis in rats. 15

Hepatic DEN metabolism produces O6-ethyl deoxyguanosine and O4- and O6-ethyl deoxythymidine, which are mutagenic and carcinogenic. 16 , 17 The effect of analyzed phytoconstituents of KM on low-density lipoprotein (LDL) receptor-related protein-6 (LRP6) and β-catenin signaling pathway, which play a role in hepatocellular carcinoma (HCC), was also studied in silico.

Methods

Chemicals and consumables

Diethylnitrosamine 0.01% (Catalogue number - D0516) from TCI chemicals, Tokyo, Japan, assay kits for liver function test from Spain-based Spinreact, silymarin 50mg/kg body weight/day (Item Number – 46791) from Micro Labs Limited, India, Kadukkai maathirai (MMP14013) from India-based SKM Siddha and Ayurveda (GMP certified) Company (India) Ltd. Good laboratory-grade chemicals were used.

Animals

Ethical statement: Seven-week-old female Sprague Dawley rats (150-200 g), procured from the Central Animal Research Facilities (CARF) of Kasturba Medical College, Manipal Academy of Higher Education, Manipal were used in the study after getting approval from the Institutional Animal Ethics Committee approval (IAEC/KMC/19/2016 dated 16.03.2016). Guidelines given by the Committee for Control and Supervision of Experiments on Animals (CCSEA), Government of India, New Delhi for the use of laboratory animals were followed for the maintenance of animals. 18 All efforts were made to ameliorate suffering of animals. All the rats were observed daily to check their health and ensure continuous access to food and water. Bedding in the cages were changed daily to provide healthy living conditions. The location of the animal cage was not changed throughout the study. The rats were acclimatized and maintained at 27 ± 3°C, humidity of 60 ± 10%, and a 12 h light/dark cycle. No procedures were done which would cause sustained pain. Anesthetics and the method of euthanasia used was as per guidelines of CCSEA.

Reporting Guidelines: The authors confirm that they followed and adhered to ARRIVE 2.0 Checklist for their study. ARRIVE CHECKLIST [Internet]. figshare; 2024 [cited 2024 Jun 7]. Available from: https://figshare.com/articles/dataset/ARRIVE_CHECKLIST/25910563/1. 76

Study design: The rats were randomised into 2 groups based on their body weight: normal control (n=6) and toxic control (n=30) rats.

Induction of liver cancer: The number (n=6) of animals in each group was based on earlier study. 19 The groups were as follows: The normal control (group 1) consisted of a total of 6 rats and received drinking water for 16 weeks. The toxic control group (DEN) consisted of a total of 30 rats, which received DEN 0.01% for sixteen weeks through drinking water for induction of HCC. 20 At the end of 16 weeks, animals were divided into 5 groups (n=6/group) and received treatment orally as follows. Group 2- toxicant control and received gum acacia 2% 1 mL/kg orally for 4 weeks. 21 Group 3, 4, 5- test drug KM36, 72, 144 mg/kg body weight orally for 4 weeks respectively. 22 Group 6- received Silymarin (50 mg/kg body weight) orally for 4 weeks. 23

At the end of the study (total of 20 weeks) blood was drawn by retroorbital puncture. The animals of all groups were euthanised by administering pentobarbitone intraperitoneally in a dose of 200 mg/kg body weight, 24 then livers were dissected for histopathology and polyacrylamide gel electrophoresis.

Parameters assessed

  • • Parameters to evaluate hepatoprotective potential of KM

    After 4 weeks of KM treatment, under ketamine anesthesia (50 mg/kg i.p), 25 blood was withdrawn from all the rats from each group to estimate the serum AST, ALT, ALP, bilirubin, and total protein levels using kits (Aspen Laboratory). 26

  • • Parameters to evaluate whether KM has any anticancer effect

Determination of liver weight and nodule count

The liver of each animal was weighed and relative weight was calculated. The nodules on the liver were counted, and an intergroup comparison was made.

Determination of body weight

Weight was measured at the end of study by using a metis electronic weighing balance. The weight difference was calculated.

Histopathological evaluation

10% formalin was used as the fixative. Paraffin-embedded wax blocks were prepared and the tissue section was prepared at 4μm thickness. The hepatic tissue was stained with hematoxylin-eosin and studied. 27 Regarding the animal group, the assessor was blinded.

Polyacrylamide gel electrophoresis for the separation of proteins and mass spectrometry for the identification of proteins.

Sample Preparation and Electrospray-ionisation Quadrapole time of fight mass (ESI/QTOF) liquid chromatography and mass spectrometry analysis (LC-MS). Tissue extract was prepared, and proteins were separated by polyacrylamide gel electrophoresis. LC-MS analysis was used to identify the protein that was differentially expressed in response to DEN administration. The expressed protein was identified by coomassie staining, separated from PAGE gel, and subjected to LC-MS analysis using MASCOT Ver 2.3. 28

In-silico analysis of phytoconstituents of KM against β catenin and LRP6 in HCC

The binding mode and interaction of β catenin and LRP6-E3 with each of the derived list of phytoconstituents of Kadukkai maathirai was performed using AutoDock Vina software. 29 , 30 Grid boxes were set at two binding sites of the armadillo repeat region of β catenin and their XYZ coordinates include X: 107.640 Y: -29.892 Z: 1.991 Å and X: 102.640 Y: 9.850 Z: 29.741 Å respectively with a grid size of 40. Whereas the XYZ coordinates for LRP6-E3 were defined by establishing a grid box with the dimensions of X: -29.376 Y: 20.133 Z: -10.560 Å with a grid size of 40, The interactions of β catenin and LRP6 protein-ligand conformations, including hydrogen, and hydrophobic bonds along with their interacting residues were analyzed using BIOVIA Discovery Studio Visualizer. 31 The 2D structures of phytoconstituents present in KM were collected from the PubChem Compound database. A total of 19 structures were sketched, prepared, and saved in MDL mol format using ChemSketch 2019 2.2 32 and saved as PDBQT format. The 3D structure of β catenin (PDB ID: 1JPW) and LRP6 (PDB ID: 3S8V) were retrieved from Protein Data Bank (RCSB PDB), optimized, minimized their energy and saved as PDB format.

Analysis of extract using Gas chromatography-mass spectroscopy (GC-MS)

It was done with Shimadzu -QP2010. Column (30m length) used was RTX-5. Interface temperature 280 °C and ion source was 200 °C. Sample was injected (1 μL) for analysis and flow rate retained at 1 mL/minute. MS spectrum achieved was identified and compared with NIST library for confirmation of compounds. 33

Statistical analysis

The data of control, test drug control, and experimental groups were presented in the form of mean ± SD, and one-way ANOVA and post hoc Tukey's test (SPSS version 16) were performed. Statistical significance was considered at p<0.05.

Results

Hepatoprotective potential of KM

Biochemical estimation in serum

Serum AST, ALP, ALT, and TBIL in DEN alone treated animals increased significantly in comparison to normal control indicating liver damage (Table 1). KM 36 mg/kg and KM72 mg/kg in DEN-treated groups showed a fall in the AST, ALT, ALP, and TBIL levels compared to animals that received DEN alone but it was not statistically significant. Other parameters were not affected significantly (Table 1).

Table 1. Effect of KM on liver function in DEN-induced HCC model in rats.

GroupsSerum AST (U/L)Serum ALT (U/L)Serum ALP (U/L)Serum TBIL (mg/dL)Serum Albumin (g/dL)
Normal control 59.0±7.535.4±8.7120.8±20.00.03±0.011.44±0.3
DEN 145.5±24.1* 99.0±14.8* 274.3±69.1* 0.126±0.08* 0.9±0.1
DEN+KM36 mg/kg 107.7±10.473.9±8.7243.6±14.70.036±0.001.3±0.1
DEN+KM72 mg/kg 131.0±26.493.8±32.6283.6±42.50.068±0.061.3±0.4
DEN+KM144 mg/kg 85.5±13.2 # , € , ¥ 71.1±10.0257.25±26.20.035±0.020.9±0.1
DEN+Silymarin 136.2±37.183.15±18.8280.75±82.90.099±0.020.9±0.1

* p<0.05 versus control.

# p<0.05 versus DEN.

€ p<0.05 versus DEN+KM72 mg/kg.

¥ p<0.05 versus DEN+Silymarin, (Values - Mean ±SD).

Bodyweight/Organ weight/Nodule count:

Body weight decreased significantly and relative liver weight increased in the DEN-induced HCC group versus control. These were altered favorably(p<0.05) in DEN-treated rats who received KM 36, 72, 144 mg/kg, and silymarin as compared to DEN-alone treated rats (Table 2). A decrease (p<0.05) in nodule count in rats treated with KM 36 mg/kg, KM 72 mg/kg, and silymarin was observed in comparison to DEN group (Table 2, Figure 1).

Table 2. Effect of KM on body weight, relative weight of liver and nodule count in DEN-induced hepatocellular carcinoma model in rats.

GroupsNodule countRelative weight of liver (g)Bodyweight(g)
Normal control 00.02±0.002257.5±8.8
DEN (Diethylnitrosamine) 107±4.0* 0.09±0.017 * 165.3±4.1*
DEN+KM 36 mg/kg 72.0±8.1 # , € 0.03±0.005 # 222.6±9.5 #
DEN+KM 72 mg/kg 84.4±11.8 # 0.04±0.004 # 200.2±3.7 #
DEN+KM 144 mg/kg 97.5±2.60.04±0.005 # 212.7±16.8 #
DEN+Silymarin 59.7±4.1 # , ¥ , € 0.04±0.007 # 200.0±8.4 #

* p<0.05 versus control.

# p < 0.05 versus DEN.

€ p< 0.05 versus DEN+KM144.

¥ p<0.05 versus DEN+KM72. Values: Mean±SD.

cc102fb6-efba-493f-8168-ac1231518961_figure1.gif

Figure 1. Effect of KM on the gross (macroscopic) appearance of liver in DEN-induced HCC model in rats. Yellow arrows indicate nodules.

1A (Normal control): Normal morphology of liver with smooth-surfaced hepatic lobes in the control animal. 1B (DEN): DEN alone administered group showed highly enlarged nodules with several foci on the surface of the liver and many greyish-white nodules, indicative of HCC. 1C (DEN +KM 36 mg/kg), 1D (DEN +KM 72 mg/ kg), 1E (DEN+KM 144 mg/kg), 1F (DEN + silymarin 50 mg/kg) groups showed relatively less foci on the hepatic surface and very few nodules when compared to 1B (DEN).

Histopathological evaluation of the liver

Figure 2A, 2B (normal control): Showed normal liver structure, Figure 2C, 2D (DEN control): Showed an invasive tumor involving irregular nodules divided by thin fibrous septae and composed of solid sheets and broad trabeculae of neoplastic hepatocytes with round to polygonal cells, irregular nuclei, prominent nucleoli, vesicular chromatin, moderate to abundant granular eosinophilic cytoplasm, mitotic figures, scattered with numerous variably dilated sinusoids, flattened endothelial cells and focal bile pigments. The presence of many areas of high vascularity with several groups of cut sections of blood vessels and destruction of the typical pattern of hepatic cords/hepatocyte arrangement is indicative of hepatocellular carcinoma. Figures 2E, 2F (DEN+KM36), Figures 2G, 2H (DEN+ KM72), Figures 2I, 2J(DEN+KM144): The structure of liver looked normal with hexagonal hepatic lobules, a central vein in its center. However, there were areas showing features of HCC like well-vascularized tumours with thick trabeculae, distinct acinar pattern, some areas of vascular invasion, and signs of mild cytoplasmic vacuolar degeneration. However, the severity of the features of HCC in this group was very mild when compared with that of DEN. Figures 2K, 2L (DEN+ Silymarin): There were areas of mild cytoplasmic vacuolar degeneration and high vascularity indicative of HCC. But it was less when compared with that of DEN group. In general, there were normal liver tissues in large areas compared to the areas with features of HCC.

cc102fb6-efba-493f-8168-ac1231518961_figure2.gif

Figure 2. Effect of KM on histopathology of the liver in DEN-induced HCC model in rats; Qualitative assessment of ‘haematoxylin and eosin (H & E) stained liver tissue sections’ were observed under 10× and 40× magnifications; CV-Central vein, BV-Blood vessels, PT-Portal triad.

Polyacrylamide Gel Electrophoresis for the separation of proteins and mass spectrometry for the identification of proteins

Ladder: Lanes (1–4) - normal control and test drug control groups; Lane 5 - DEN alone, Lanes 6–9 - DEN for 16 weeks followed by treatment with KM 36, 72 and 144 mg/kg, and silymarin, respectively. The protein lysate was prepared and subjected to separation by PAGE (Figure 3A). DEN control group had a band in the range of 25-30 kda as analysed by Polyacrylamide Gel Electrophoresis (PAGE). In comparison to lanes 5 and 6, band thickness was more in lanes 7, 8, and 9; this was confirmed by mass spectrometry and identified as GSTM1 (Figure 3B).

cc102fb6-efba-493f-8168-ac1231518961_figure3.gif

Figure 3. (A) Agarose gel electrophoresis of extraction from the liver of rats; (B) Mass spectrometry analysis of extraction from the liver of rats.

In-silico analysis of interactions of phytoconstituents of KM with β catenin

The molecular docking study revealed that nine phytoconstituents out of 19 made interactions with β catenin binding site that is residue number 219 to 335 (C-terminal helical region of Tcf-4interaction region) except D-allose which showed interactions between the residues 429 to 508 (extended region of Tcf-4 peptide interaction region) of β catenin. Their binding energies, number of interactions, and interacting residues of β catenin were tabulated in Table 3. The binding energies of the phytoconstituents ranged from -7.8 to -5.2 kcal/mol. The lowest binding energy was recorded for hexanediamide whereas, 2H-Pyran-2-one, 5,6-dihydro documented the highest among the shortlisted constituents. The phytoconstituents with interacting residues are displayed in Figure 4A and 4B as follows. Octadecadienoicacid and propylene glycol monooleate made a maximum number of interactions (8 each) whereas, Hexanediamide made the lowest number of interactions- 2 (Table 3). However, the constituents did not show any favorable interactions with the interaction site of LRP6-E3.

Table 3. Shortlisted phytoconstituents and their interactions with β catenin.

PhytoconstituentsBinding energyNo. of interactionsHydrogen bondsHydrophobic bonds
Hexanediamide-7.82-2(Phe253, lys252)
Octadecadienoicacid-6.08Lys3357 (His260, Ile296, Lys292, Phe253)
Propylene glycol monooleate-6.68Arg3767 (Tyr254, Phe253, Ile296, Lys292)
Ethyl piperonylcyanoacetate-6.44Asn2903 (His219, Phe253, Lys292)
Beta-sitosterol-7.35Phe2534(Ile296, Lys292, phe253)
Benzene, 1-methyl-2-(1-methylethyl)-5.74 - 4 (Ile296, Lys292, Phe253)
2H-Pyran-2-one, 5,6-dihydro-5.22 - 2 (Lys292, Phe253)
3,5-dibromo-1H-pyrazole-4-carboxamide-5.54-4 (Ile296, Phe253)
D-allose-6.544 (Lys435, His470) -
cc102fb6-efba-493f-8168-ac1231518961_figure4.gif

Figure 4. Representation of the interactions made by the shortlisted phytoconstituents of KM with the binding site of β catenin.

(Left: binding poses; Right: 2D images) (< 5 Å distance).

Gas chromatography-mass spectroscopy (GC-MS) analysis of test drug KM (Figure 5) (Table 4)

cc102fb6-efba-493f-8168-ac1231518961_figure5.gif

Figure 5. GC-MS analysis of the test drug Kadukkai maathirai (KM).

Table 4. Gas chromatography-mass spectroscopy (GC-MS) analysis of the test drug Kadukkai maathirai (KM).

Sl. NoR. timeCompound nameMol. FormulaMol. WeightPercentageStructure
1 24.366PiperineC17H19NO3 28566.26 cc102fb6-efba-493f-8168-ac1231518961_gra1.gif
2 11.173D-AlloseC6H12O6 180.164.97 cc102fb6-efba-493f-8168-ac1231518961_gra2.gif
3 23.177Propyleneglycol monooleateC21H40O3 3404.68 cc102fb6-efba-493f-8168-ac1231518961_gra3.gif
4 6.293LevoglucosenoneC6H6O3 1263.15 cc102fb6-efba-493f-8168-ac1231518961_gra4.gif
5 12.448Caryophyllenyl alcoholC15H26O2222.57 cc102fb6-efba-493f-8168-ac1231518961_gra5.gif
6 8.740PentadecaneC15H32 2122.06 cc102fb6-efba-493f-8168-ac1231518961_gra6.gif
7 6.964Hexanediamide, N,N'-di-benzoyloxy-C20H20N2O6 3842.00 cc102fb6-efba-493f-8168-ac1231518961_gra7.gif
8 28.308beta-SitosterolC29H50O4141.72 cc102fb6-efba-493f-8168-ac1231518961_gra8.gif
9 22.366Ethyl piperonylcyanoacetateC13H13NO4 2471.72 cc102fb6-efba-493f-8168-ac1231518961_gra9.gif
10 16.20210,12-Octadecadienoic acid, 9-oxo-C18H30O3 2941.46 cc102fb6-efba-493f-8168-ac1231518961_gra10.gif
11 16.384n-Hexadecanoic acidC16H32O2 2561.37 cc102fb6-efba-493f-8168-ac1231518961_gra11.gif
12 12.070Dodecanoic acidC12H24O2 2001.18 cc102fb6-efba-493f-8168-ac1231518961_gra12.gif
13 18.077cis-9-HexadecenalC16H30O2381.13 cc102fb6-efba-493f-8168-ac1231518961_gra13.gif
14 7.6291,4:3,6-Dianhydro-.alpha.-d-glucopyranoseC6H8O4 144.11.06 cc102fb6-efba-493f-8168-ac1231518961_gra14.gif
15 9.7743a,7-Methano-3aH-cyclopentacyclooctene, 1,4,5,6,7,8,9,9a-octahydro-1,1,7-trimethyl-, [3C15H24 2041.00 cc102fb6-efba-493f-8168-ac1231518961_gra15.gif
16 5.036Benzene, 1-methyl-2-(1-methylethyl)-C10H14 1340.94 cc102fb6-efba-493f-8168-ac1231518961_gra16.gif
17 4.1313-Aminopyrazine 1-oxideC4H5N3O1110.94 cc102fb6-efba-493f-8168-ac1231518961_gra17.gif
18 5.2282H-Pyran-2-one, 5,6-dihydro-C5H6O2 980.90 cc102fb6-efba-493f-8168-ac1231518961_gra18.gif
19 3.328Oxime-, methoxy-phenyl-C8H9NO2 1510.90 cc102fb6-efba-493f-8168-ac1231518961_gra19.gif

19 compounds were recognized by GC-MS from methanolic extract of KM. Piperine (66.26%) was the major constituent of KM. Others were D-Allose (4.97%), Propyleneglycol monoleate (4.68%), Levoglucosenone (3.15%), etc.

Discussion

N-nitroso compounds, as potential carcinogens, were first brought to the public attention as a cause of liver disease in 1937. In 1954, it was confirmed that one oral or parenteral dose of DEN (20-40 mg/kg) acts as a liver toxin, leading to severe liver necrosis in rodents. 34 , 35 In rodents, chronic parenteral and oral administration of DEN at large doses effectively induces liver tumour. 36 Pericentral foci of small dysplastic liver cells is induced by diethylnitrosamine (DEN), by ethylating DNA 37 , 38 leading to cirrhosis and multifocal HCC. 39 It predominantly targets the liver, where it is biologically transformed by CYP450-dependent processes that are most active in centrilobular hepatocytes. 40 The main metabolising pathways of DEN in rodents and humans are very similar. 41 which results in reactive species responsible for the development of methylated compounds, leading to carcinogenesis. Previous studies have shown that in DEN-treated group, there was distorted liver architecture with swollen cells, hyperplasia, and dysplasia, with infiltration of inflammatory cells, indicating carcinogenesis. 42 – 44 In the present study, similar histopathological changes occurred in DEN-treated groups.

DEN-induced hepatic injury leads to instability of metabolism by the liver with concomitant variations in the activities of enzymes. 45 An increase in the level of transaminases indicates liver damage. Liver toxicity leads to the breakdown of the cell membrane and further spillage of the aminotransferases from the cytoplasm into the serum, thus increasing the serum aminotransferase levels. 46 Aminotransferases are known as diagnostic and reliable markers of liver damage. In our study, the level of liver enzymes and bilirubin were increased significantly reflecting liver damage in DEN alone treated rats. In rats which received DEN with KM, the enzyme levels were reduced when compared to DEN alone treated rats, though it was not statistically significant. Probably, increasing the duration of treatment (> 4 weeks) with KM may have produced further improvement in liver functions.

Weight loss is an important symptom of DEN-induced cancer. DEN causes alterations which is reflected as worsening of liver function during pathogenesis of liver fibrosis. 47 Damaged to the liver results in loss of appetite. Administration of KM in varying doses following induction of HCC by DEN prevented body weight loss which could be due to its protective action against liver damage.

In this study, the relative liver weights of DEN-treated rats were significantly high compared to normal which has been commonly observed and reported in liver cancer. 48 Treatment with KM prevented an increase in liver weight. DEN gets metabolized by microsomal enzymes in a sequence of intermediate responses leading to development of mutagenic metabolites. The free radicals generated in the process trigger cell proliferation, appearance of liver nodules and a rise in the weight of the liver. 49 Low levels of ROS do not cause any damage to the cell process, but high ROS level damages proteins, lipids and DNA by nonspecific process. 50 Glutathione-S transferase mu 1 (GSTM1) is a phase II detoxifying enzyme. It plays a role in the detoxification of environmental carcinogen metabolites, suggesting that its downregulation may contribute to HCC carcinogenesis secondary to ROS-facilitated oxidative damage. 51 The expression of GSTM1 was much higher in the KM and silymarin treatment groups versus control and DEN groups.

Eclipta alba, a constitiuent of KM has been to shown to have antiproliferative property in HepG2 cell lines. Eclipta alba extract could induce DNA fragmentation and thus apoptosis in hepatic cell lines. 52 Alkaloids present in Eclipta alba can damage the DNA of cancer cells. 53 Eclipta alba is a well-known liver regenerative herb with protective effect on liver parenchymal cells and its cell membrane resulting in a decrease in enzyme seepage. 54 An important constituent of Terminalia chebula is chebulic acid. 55 Chebulic acid has been established to have hepatoprotective and antioxidant effects in various liver disease models. 56 In a previous study, Terminalia chebula stimulated apoptosis with membrane bleb and apoptotic bodies, thus rendering protection to macromolecules in DEN model by stabilizing the redox balance. 57

Piperine, present in Piper nigrum of Kadukkai maathirai has demonstrated dose-dependent cytotoxicity against HepG2 cells. It inhibits catalase and induces mitochondria-mediated cell death by H2O2 in these cells. Further, analysis revealed that it had receptor tyrosine kinase inhibition property which led to inhibition of HCC progression. 58 Glucose, a major source of energy for cancer cells, is transported into cells via glucose transporters (GLUTs). These transporters are overexpressed in cancer cells which helps in enhanced glucose uptake by the cancer cells. Studies have shown that D-allose inhibited GLUT1 expression in cell lines of hepatocellular carcinoma thus reducing glucose utilization by cancer cells. 59

Citrus fruits contain valuable bioflavonoids that have bioactivities on apoptosis induction in vitro. 60 The phytochemicals present in citrus fruits exhibit antioxidant, anticancer, and anti-inflammatory activities. 61 – 63 The constituent plants of KM could have exerted synergistic effects to protect against DEN induced hepatic damage.

Constitutive Wnt signalling has been document as a key factor in the development of various cancers. β catenin is a multifunctional protein in Wnt signalling pathway. Transcription factor 4 (Tcf4) is a peptide that interacts with the armadillo repeat region of β catenin leading to production of downstream transcription factors for malignant growth. The Tcf4 interaction regions on β catenin have been studied and used as templates for analysis. 64 , 65 Among the phytoconstituents of KM, D-allose contributed a maximum number of hydrogen interactions-4 with Lys435, His470. Octadecadienoicacid and propylene glycol monooleate showed the maximum number of interactions of eight with one hydrogen interaction. All other phytoconstituents showed interactions with this region of β catenin. With this analysis, we hypothesize that these constituents could interact with this region simultaneously or in part, thus potentially modulating the transcription process by preventing Tcf4 interaction with β catenin. We also noted that the shortlisted constituents would not modulate the LRP6-DKK1 mediated Wnt stimulation and subsequent pathway activation as they did not make any interactions with the LRP6-E3 binding site. In the present study beta sitosterol was confirmed in the GCMS analysis of KM. Earlier studies have reported that beta sitosterol downregulates beta catenin expression inhibits growth and induces apoptosis in colon cancer cells. 66 We presume that the active phytoconstituents of Kadukkai maathirai could modulate the intracellular transcription process by inhibiting the armadillo repeat region of β catenin.

Conclusion

We have concluded that Kadukkai maathirai could be potentially useful as a supplement in therapy of hepatocellular carcinoma. Further studies are needed to investigate its mechanism of action including validation of its target in hepatocellular carcinoma before exploring its efficacy in clinical studies.

Ethics statement

Seven-week-old female Sprague Dawley rats (150-200 g) procured from the Central Animal Research Facilities (CARF) of Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal were used in the study after getting approval from the Institutional Animal Ethics Committee approval (IAEC/KMC/19/2016 dated 16.03.2016). Guidelines given by the Committee for Control and Supervision of Experiments on Animals, Government of India, New Delhi for the use of laboratory animals were followed for the maintenance of animals. 18

Data availability

Underlying data

Reporting guidelines

Figshare: ARRIVE checklist for Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study https://doi.org/10.6084/m9.figshare.25910563.v1 77

(Shetty MS. ARRIVE CHECKLIST [Internet]. figshare; 2024 [cited 2024 Jun 7]. Available from: https://figshare.com/articles/dataset/ARRIVE_CHECKLIST/25910563/1)

Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).

Acknowledgments

The authors would like to thank Manipal Academy of Higher Education, Manipal for providing the facilities to carry out the research.

References

  • 1.  McGlynn KA, Petrick JL, London WT: Global Epidemiology of Hepatocellular Carcinoma: An Emphasis on Demographic and Regional Variability. Clin. Liver Dis. 2015; 19: 223–238. PubMed Abstract | Publisher Full Text | Free Full Text
  • 2.  Singal AG, El-Serag HB: Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin. Gastroenterol. Hepatol. 2015; 13: 2140–2151. PubMed Abstract | Publisher Full Text | Free Full Text
  • 3.  Sachdeva M, Chawla YK, Arora SK: Immunology of hepatocellular carcinoma. World J. Hepatol. 2015; 7: 2080–2090. PubMed Abstract | Publisher Full Text | Free Full Text
  • 4.  Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, et al.: Hepatocellular carcinoma: From diagnosis to treatment. Surg. Oncol. 2016; 25: 74–85. Publisher Full Text
  • 5.  op den Winkel M , Nagel D, Sappl J, et al.: Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort. PLoS One. 2012; 7: e45066. PubMed Abstract | Publisher Full Text | Free Full Text
  • 6.  Bellmunt J, Eisen T, Fishman M, et al.: Experience with sorafenib and adverse event management. Crit. Rev. Oncol. Hematol. 2011; 78: 24–32. Publisher Full Text
  • 7.  Mazzoccoli G, Miele L, Oben J, et al.: Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib. Curr. Drug Targets. 2016; 17: 783–799. PubMed Abstract | Publisher Full Text
  • 8.  Fitzmorris P, Shoreibah M, Anand BS, et al.: Management of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2015; 141(5): 861–876. Publisher Full Text
  • 9.   Therapeutic Index Siddha (Hospital Pharmacopoeia). SKM Siddha and ayurveda company; 2010.
  • 10.  Amuthan A: Physico-chemical evaluation of kadukkai maathirai and its tablet formulation, a Siddha iron preparation used in anemia.2012; 1(1): 3–8.
  • 11.  Wagner H, Geyer B, Kiso Y, et al.: Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea. Planta Med. 1986; 52: 370–374. Publisher Full Text
  • 12.  Vijayakumar RS, Surya D, Nalini N: Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Rep. 2004; 9(2): 105–110. PubMed Abstract | Publisher Full Text
  • 13.  Wang YH, Morris-Natschke SL, Yang J, et al.: Anticancer Principles from Medicinal Piper (胡椒 Hú Jiāo) Plants. J. Tradit. Complement. Med. 2014; 4(1): 8–16. PubMed Abstract | Publisher Full Text | Free Full Text
  • 14.  Selvendiran K, Sakthisekaran D: Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo(a) pyrene induced lung carcinogenesis. Biomed. Pharmacother. 2004; 58(4): 264–267. PubMed Abstract | Publisher Full Text
  • 15.  Shetty M, Shenoy S, Kumar N, et al.: Kadukkai maathirai (A polyherbal traditional siddha formulation) prevents d-galactosamine induced hepatic necrosis in rats. Indian J. Tradit. Knowl. 2020; 19(4): 708–713.
  • 16.  Verna L: N-Nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol. Ther. 1996; 71(1-2): 57–81. PubMed Abstract | Publisher Full Text
  • 17.  Kerdput V, Nilbu-nga C, Kaewnoonual N, et al.: Therapeutic efficacy of a Dioscorea membranacea extract in a rat model of hepatocellular carcinoma: Histopathological aspects. J. Tradit. Complement. Med. 2021; 11(5): 400–408. PubMed Abstract | Publisher Full Text | Free Full Text
  • 18.  Chief Editor: Government of india notifies the rules for breeding of and conducting animal experiments. Indian J. Pharm. 1999; 31(1): 92–95.
  • 19.  Thomas S, Paul J, Shrungeswara A, et al.: Annona muricata fruit extract protects against diethylnitrosamine-induced hepatocellular cancer in rats. Asian Pac. J. Trop. Med. 2019; 12(6): 272. Publisher Full Text
  • 20.  Jayakumar S, Madankumar A, Asokkumar S, et al.: Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol. Cell. Biochem. 2012; 360(1-2): 51–60. PubMed Abstract | Publisher Full Text
  • 21.  Babiker R, Elmusharaf K, Keogh MB, et al.: Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial. Lipids Health Dis. 2018; 17(1): 56. PubMed Abstract | Publisher Full Text | Free Full Text
  • 22.  Kadukkai maathirai (a polyherbal traditional siddha formulation) prevents D-galactosamine induced hepatic necrosis in rats. Indian J. Tradit. Knowl. 2020; 19(4). Publisher Full Text
  • 23.  Pradeep K, Victor Raj Mohan C, Gobianand K, et al.: Silymarin: An Effective Hepatoprotective Agent Against Diethylnitrosamine-Induced Hepatotoxicity in Rats. Pharm. Biol. 2007; 45(9): 707–714. Publisher Full Text
  • 24.  Laferriere CA, Pang DS: Review of Intraperitoneal Injection of Sodium Pentobarbital as a Method of Euthanasia in Laboratory Rodents. J. Am. Assoc. Lab. Anim. Sci. 2020; 59(3): 254–263. PubMed Abstract | Publisher Full Text | Free Full Text
  • 25.  Struck MB, Andrutis KA, Ramirez HE, et al.: Effect of a short-term fast on ketamine-xylazine anesthesia in rats. J. Am. Assoc. Lab. Anim. Sci. 2011; 50(3): 344–348. PubMed Abstract
  • 26.  Thapa BR, Walia A: Liver function tests and their interpretation. Indian J. Pediatr. 2007; 74(7): 663–671. Publisher Full Text
  • 27.  Titford M: The long history of hematoxylin. Biotech. Histochem. 2005; 80(2): 73–78. PubMed Abstract | Publisher Full Text
  • 28.  Petrov A, Tsa A, Puglisi JD: Analysis of RNA by Analytical Polyacrylamide Gel Electrophoresis. Methods Enzymol. 2013; 530: 301–313. PubMed Abstract | Publisher Full Text
  • 29.  Eberhardt J, Santos-Martins D, Tillack AF, et al.: AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J. Chem. Inf. Model. 2021; 61(8): 3891–3898. PubMed Abstract | Publisher Full Text | Free Full Text
  • 30.  Trott O, Olson AJ: AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010; 31(2): 455–461. PubMed Abstract | Publisher Full Text | Free Full Text
  • 31.  BIOVIA Discovery Studio Visualizer|Dassault Systèmes. Accessed April 4, 2024. Reference Source
  • 32.  Free Chemical Drawing Software for Students|ChemSketch|ACD/Labs. Accessed April 4, 2024. Reference Source
  • 33.  Padmakiran C, Prasad U, Koppala NS: Transdermal absorption studies of Nirgundi (Vitex Negundo Linn) taila and Kashaya (Decoction) with the aid of gas chromatography-mass spectrometry. J. Ayurveda. 2023; 17(2): 79. Publisher Full Text
  • 34.  CLINICAL MANIFESTATIONS AND STUDIES IN PARENCHYMATOUS HEPATITIS. Ann. Intern. Med. 1937; 10(8): 1144. Publisher Full Text
  • 35.  Barnes JM, Magee PN: Some Toxic Properties of Dimethylnitrosamine. Occup. Environ. Med. 1954; 11(3): 167–174. PubMed Abstract | Publisher Full Text | Free Full Text
  • 36.  Magee PN, Barnes JM: The Production of Malignant Primary Hepatic Tumours in the Rat by Feeding Dimethylnitrosamine. Br. J. Cancer. 1956; 10(1): 114–122. PubMed Abstract | Publisher Full Text | Free Full Text
  • 37.  Goldfarb S, Pugh TD, Koen H, et al.: Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy. Environ. Health Perspect. 1983; 50: 149–161. PubMed Abstract | Publisher Full Text | Free Full Text
  • 38.  Koen H, Pugh TD, Goldfarb S: Centrilobular distribution of diethylnitrosamine-induced hepatocellular foci in the mouse. Lab. Investig. 1983; 49(1): 78–81. PubMed Abstract
  • 39.  Pascale RM, Simile MM, Feo F: Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy. Anticancer Res. 13(5A): 1341–1356. PubMed Abstract
  • 40.  Yang CS, Tu YY, Koop DR, et al.: Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes. Cancer Res. 1985; 45(3): 1140–1145. PubMed Abstract
  • 41.  Yoo JS, Guengerich FP, Yang CS: Metabolism of N-nitrosodialkylamines by human liver microsomes. Cancer Res. 1988; 48(6): 1499–1504. PubMed Abstract
  • 42.  Thomas S, Paul J, Shrungeswara A, et al.: Annona muricata fruit extract protects against diethylnitrosamine-induced hepatocellular cancer in rats. Asian Pac. J. Trop. Med. 2019; 12: 272. Publisher Full Text
  • 43.  Gupta C, Vikram A, Tripathi DN, et al.: Antioxidant and antimutagenic effect of quercetin against DEN induced hepatotoxicity in rat. Phytother. Res. 2010; 24(1): 119–128. PubMed Abstract | Publisher Full Text
  • 44.  Singh D, Singh M, Yadav E, et al.: Attenuation of diethylnitrosamine (DEN) – Induced hepatic cancer in experimental model of Wistar rats by Carissa carandas embedded silver nanoparticles. Biomed. Pharmacother. 2018; 108: 757–765. PubMed Abstract | Publisher Full Text
  • 45.  Bulle F, Mavier P, Zafrani ES, et al.: Mechanism of γ-glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: A histochemical, biochemical and molecular approach. Hepatology. 1990; 11(4): 545–550. PubMed Abstract | Publisher Full Text
  • 46.  Lippert M, Papadopoulos N, Javadpour N: Role of lactate dehydrogenase isoenzymes in testicular cancer. Urology. 1981; 18: 50–53. PubMed Abstract | Publisher Full Text
  • 47.  George J, Chandrakasan G: Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin. Biochem. 2000; 33(7): 563–570. PubMed Abstract | Publisher Full Text
  • 48.  Abe R, Okano JI, Imamoto R, et al.: Sequential analysis of diethylnitrosamine-induced hepatocarcinogenesis in rats. Exp. Ther. Med. 2012; 3(3): 371–378. PubMed Abstract | Publisher Full Text | Free Full Text
  • 49.  Panigrahy D, Edin ML, Lee CR, et al.: Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J. Clin. Invest. 2012; 122: 178–191. PubMed Abstract | Publisher Full Text | Free Full Text
  • 50.  Xie C, Yi J, Lu J, et al.: N -Acetylcysteine Reduces ROS-Mediated Oxidative DNA Damage and PI3K/Akt Pathway Activation Induced by Helicobacter pylori Infection. Oxidative Med. Cell. Longev. 2018; 2018: 1–9. PubMed Abstract | Publisher Full Text | Free Full Text
  • 51.  Lu Y, Zhou J, Zhang J, et al.: Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma. Biomed. Pharmacother. 2019; 120: 109532. Publisher Full Text
  • 52.  Chaudhary H, Dhuna V, Singh J, et al.: Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: An in vitro study. J. Ethnopharmacol. 2011; 136(2): 363–367. PubMed Abstract | Publisher Full Text
  • 53.  Abdel-Kader MS, Bahler BD, Malone S, et al.: DNA-damaging steroidal alkaloids from Eclipta alba from the suriname rainforest. J. Nat. Prod. 1998; 61: 1202–1208. PubMed Abstract | Publisher Full Text
  • 54.  Chaudhary H, Jena PK, Seshadri S: In Vivo Evaluation of Eclipta alba Extract as Anticancer and Multidrug Resistance Reversal Agent. Nutr. Cancer. 2014; 66(5): 904–913. Publisher Full Text
  • 55.  Juang LJ, Sheu SJ, Lin TC: Determination of hydrolyzable tannins in the fruit ofTerminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J. Sep. Sci. 2004; 27(9): 718–724. PubMed Abstract | Publisher Full Text
  • 56.  Lee HS, Jung SH, Yun BS, et al.: Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch. Toxicol. 2007; 81: 211–218. PubMed Abstract | Publisher Full Text
  • 57.  Srigopalram S, Jayraaj IA: Effect of Terminalia chebula Retz on den induced hepatocellular carcinogenesis in experimental rats. Int. J. Pharm. Pharm. Sci. 2012.
  • 58.  Gunasekaran V, Elangovan K, Niranjali DS: Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. Food Chem. Toxicol. 2017; 105: 106–118. PubMed Abstract | Publisher Full Text
  • 59.  Noguchi C, Kamitori K, Hossain A, et al.: D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression. Tohoku J. Exp. Med. 2016; 238(2): 131–141. PubMed Abstract | Publisher Full Text
  • 60.  Banjerdpongchai R, Wudtiwai B, Khaw-on P, et al.: Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways. Tumour Biol. 2016; 37(1): 227–237. PubMed Abstract | Publisher Full Text | Free Full Text
  • 61.  Chiba H, Uehara M, Wu J, et al.: Hesperidin, a Citrus Flavonoid, Inhibits Bone Loss and Decreases Serum and Hepatic Lipids in Ovariectomized Mice. J. Nutr. 2003; 133(6): 1892–1897. PubMed Abstract | Publisher Full Text
  • 62.  Yumnam S, Park HS, Kim MK, et al.: Hesperidin Induces Paraptosis Like Cell Death in Hepatoblatoma, HepG2 Cells: Involvement of ERK1/2 MAPK. Calvisi D, ed. PLoS One. 2014; 9(6): e101321. Publisher Full Text
  • 63.  Roohbakhsh A, Parhiz H, Soltani F, et al.: Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci. 2015; 124: 64–74. PubMed Abstract | Publisher Full Text
  • 64.  Cheng Z, Biechele T, Wei Z, et al.: Crystal structures of the extracellular domain of LRP6 and its complex with DKK1. Nat. Struct. Mol. Biol. 2011; 18(11): 1204–1210. PubMed Abstract | Publisher Full Text | Free Full Text
  • 65.  Poy F, Lepourcelet M, Shivdasani R, et al.: Structure of a human Tcf4–β-catenin complex. Nat. Struct. Mol. Biol. 2001; 8: 1053–1057. PubMed Abstract | Publisher Full Text
  • 66.  Gu S, Liu F, Xie X, et al.: β-Sitosterol blocks the LEF-1-mediated Wnt/β-catenin pathway to inhibit proliferation of human colon cancer cells. Cell Signal. 2023 Apr; 104: 110585. Epub 2023 Jan 2. PubMed Abstract | Publisher Full Text
  • 67.  Shetty MS: Macroscopic appearance of the liver.April 2024. Publisher Full Text
  • 68.  Shetty MS: Histopathology.April 2024. Publisher Full Text
  • 69.  Shetty MS: Polyacrylamide Gel Electrophoresis for the separation of proteins and mass spectrometry for the identification of proteins.April 2024. Publisher Full Text
  • 70.  Shetty MS: In-silico analysis of interactions of phytoconstituents of KM with β catenin.April 2024. Publisher Full Text
  • 71.  Shetty MS: Gas chromatography-mass spectroscopy (GC-MS) analysis of test drug KM.April 2024. Publisher Full Text
  • 72.  Shetty MS: Effect of KM on liver function in DEN-induced HCC model in rats.April 2024. Publisher Full Text
  • 73.  Shetty MS: Effect of “KM on body weight, relative weight of liver and nodule count in DEN-induced hepatocellular carcinoma model in rats”.April 2024. Publisher Full Text
  • 74.  Shetty MS: Shortlisted phytoconstituents and their interactions with β catenin.April 2024. Publisher Full Text
  • 75.  Shetty MS: Gas chromatography-mass spectroscopy (GC-MS) analysis of the test drug Kadukkai maathirai (KM).April 2024. Publisher Full Text
  • 76.  Shetty MS: Raw Data.2024.
  • 77.  Shetty MS: ARRIVE CHECKLIST.June 2024. Publisher Full Text

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 17 Jun 2024
Comment
Author details Author details
Competing interests
Grant information
Article Versions (2)
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
 - -
Citations
SEE MORE DETAILS
CITE
how to cite this article
Shetty M, Shenoy S, Amuthan A et al. Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2024, 13:639 (https://doi.org/10.12688/f1000research.145961.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 22 Oct 2024
Revised
Views
3
Cite
Reviewer Report 09 Jan 2025
Afrah Fatthi Salama, Professor of Biochemistry, Faculty of Science, Tanta University, Tanta, Gharbia Governorate, Egypt 
Approved with Reservations
VIEWS 3
https://doi.org/10.5256/f1000research.172786.r345193
  • Page 5, under Animals, please add Reference for using female rats, giving reason for using female not male 
  • You gave DEN, in drinking water as Reference no. 20, this
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Salama AF. Reviewer Report For: Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2024, 13:639 (https://doi.org/10.5256/f1000research.172786.r345193)
The direct URL for this report is:
https://f1000research.com/articles/13-639/v2#referee-response-345193
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Report a concern
Version 1
VERSION 1
PUBLISHED 17 Jun 2024
Views
21
Cite
Reviewer Report 21 Aug 2024
Talha Bin Emran, BGC Trust University Bangladesh, Chittagong, Chittagong Division, Bangladesh 
Approved with Reservations
VIEWS 21
https://doi.org/10.5256/f1000research.159988.r309884
1. The results and discussion section could benefit from a more detailed exploration of the findings. It would be helpful to provide additional insight into why certain effects are coming in to existence and what could be the possible reason behind ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Emran TB. Reviewer Report For: Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2024, 13:639 (https://doi.org/10.5256/f1000research.159988.r309884)
The direct URL for this report is:
https://f1000research.com/articles/13-639/v1#referee-response-309884
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Report a concern
Views
18
Cite
Reviewer Report 21 Aug 2024
Haiyang Yu, Tianjin University of Traditional Chinese Medicine, Tianjin, China 
Approved
VIEWS 18
https://doi.org/10.5256/f1000research.159988.r309885
  1. This article demonstrates that KM can protect the liver from further damage by reducing the nodule count and reducing the relative weight of the liver. Also, this paper verifies that KM regulates the intracellular transcription process by
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Yu H. Reviewer Report For: Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2024, 13:639 (https://doi.org/10.5256/f1000research.159988.r309885)
The direct URL for this report is:
https://f1000research.com/articles/13-639/v1#referee-response-309885
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Report a concern

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 17 Jun 2024
Comment

Open Peer Review

Reviewer Status

Alongside their report, reviewers assign a status to the article:

Approved
The paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations
A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved
Fundamental flaws in the paper seriously undermine the findings and conclusions

Reviewer Reports

Invited Reviewers
1 2 3
Version 2
(revision)
 22 Oct 24 		read
Version 1
17 Jun 24 		read read
  1. Haiyang Yu, Tianjin University of Traditional Chinese Medicine, Tianjin, China
  2. Talha Bin Emran, BGC Trust University Bangladesh, Chittagong, Bangladesh
  3. Afrah Fatthi Salama, Tanta University, Tanta, Egypt

Comments on this article

All Comments(0)

Add a comment
Sign up for content alerts

Browse by related subjects

    keyboard_arrow_left Back to all reports
    keyboard_arrow_left Back to all reports
    keyboard_arrow_left Back to all reports
    Alongside their report, reviewers assign a status to the article:
    Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
    Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
    Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
    Sign In
    If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

    The email address should be the one you originally registered with F1000.
    Email address not valid, please try again

    You registered with F1000 via Google, so we cannot reset your password.

    To sign in, please click here.

    If you still need help with your Google account password, please click here.

    You registered with F1000 via Facebook, so we cannot reset your password.

    To sign in, please click here.

    If you still need help with your Facebook account password, please click here.

    Code not correct, please try again
    Email us for further assistance.
    Server error, please try again.